Is Rapport Therapeutics, Inc. Common Stock (RAPP) a Buy, Sell, or Hold?
NASDAQ : RAPP
Rapport Therapeutics, Inc. Common Stock — Institutional Ownership
$40.98 USD
-$1.8 (-4.21%)
- Volume
- 240.88K
- Average Volume
- 367.63K
- Market Capitalization
- $1.96B
- P/E Ratio
- -15.76
- Dividend Yield
- 0.00%
- Price Target
- $60.50
- Year High
- $44.28
- Year Low
- $13.62
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.08
Institutional Ownership Summary
Institutional Ownership %
0.60%
Investors Holding
24
change: -124 | last: 148
Increased Positions
10
change: -72 | last: 82
Reduced Positions
7
change: -27 | last: 34
New Positions
4
change: -25 | last: 29
Sold Positions
126
change: 98 | last: 28
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -56.7568 | last: 0.5676
Total Invested
11.68M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Cormorant Asset Management, LP | 2.96M | 6.19% |
| 2026-02-17 | Cormorant Asset Management, LP | 3.03M | 6.35% |
| 2026-01-21 | BlackRock, Inc. | 2.4M | 5.03% |
| 2025-11-14 | Cormorant Asset Management, LP | 3.19M | 6.70% |
| 2025-10-22 | JOHNSON & JOHNSON | 1.78M | 4.90% |
| 2025-09-18 | Sofinnova Management XI, L.L.C. ("SM XI LLC") | 1.86M | 4.00% |
| 2025-09-18 | Dr. Maha Katabi ("Katabi") | 1.86M | 4.00% |
| 2025-09-18 | Dr. James I. Healy ("Healy") | 1.95M | 4.20% |
| 2025-09-18 | Sofinnova Management XI, L.P. ("SM XI LP") | 1.86M | 4.00% |
| 2025-09-18 | Sofinnova Venture Partners XI, L.P. ("SVP XI") | 1.86M | 4.00% |
| 2025-02-13 | Third Rock Ventures V, L.P. | 7.14M | 19.50% |
| 2024-11-14 | ARCH Venture Fund XII, L.P. | 3.73M | 10.20% |
| 2024-11-13 | 95-1411037 | 13.0 | 7.10% |
| 2024-10-18 | Johnson & Johnson | 2.5M | 6.80% |
| 2024-10-18 | Johnson & Johnson Innovation-JJDC, Inc. | 2.5M | 6.80% |
| 2024-07-10 | FMR LLC | 4.98M | 13.62% |
| 2024-07-10 | Abigail P. Johnson | 4.98M | 13.62% |
| 2024-06-21 | WEST STREET LIFE SCIENCES I, L.P. | 326.57K | 0.90% |
| 2024-06-21 | GOLDMAN SACHS & CO. LLC | 2.67M | 7.50% |
| 2024-06-21 | WSLS EMP OFFSHORE INVESTMENTS, L.P. | 89728.0 | 0.30% |
| 2024-06-21 | BROAD STREET PRINCIPAL INVESTMENTS, L.L.C. | 233.74K | 0.70% |
| 2024-06-21 | WSLS EMP ONSHORE INVESTMENTS, L.P. | 237.87K | 0.70% |
| 2024-06-21 | THE GOLDMAN SACHS GROUP, INC. | 2.67M | 7.50% |
| 2024-06-21 | WSLS OFFSHORE INVESTMENTS, SLP | 327.06K | 0.90% |
| 2024-06-20 | Bihua Chen | 2.94M | 8.04% |
| 2024-06-20 | Cormorant Private Healthcare Fund IV, LP | 229.72K | 0.63% |
| 2024-06-20 | Cormorant Global Healthcare GP IV, LLC | 229.72K | 0.63% |
| 2024-06-20 | Cormorant Global Healthcare Master Fund, LP | 1.28M | 3.51% |
| 2024-06-20 | Cormorant Global Healthcare GP, LLC | 1.28M | 3.51% |
| 2024-06-20 | Cormorant Private Healthcare Fund III, LP | 694.44K | 1.90% |
| 2024-06-20 | Cormorant Global Healthcare GP III, LLC | 694.44K | 1.90% |
| 2024-06-20 | Cormorant Private Healthcare Fund V, LP | 732.45K | 2.00% |
| 2024-06-20 | Cormorant Global Healthcare GP V, LLC | 732.45K | 2.00% |
| 2024-06-20 | Cormorant Asset Management, LP | 2.94M | 8.04% |
RAPP Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $30.34 | 46.98M | $1.43B | $52.64M | $11.48M | $1.38B |
| 2024-12-31 | $17.74 | 20.74M | $367.9M | $56.8M | $1.48M | $312.57M |
| 2023-12-31 | $20.80 | 18.08M | $376.04M | $70.17M | $2.15M | $308.02M |
| 2022-12-31 | $20.80 | 20.12M | $418.43M | $31.16M | $10.44M | $397.71M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31.29 | 47.24M | $1.48B | $78.06M | $10.8M | $1.41B |
| 2025-12-31 | $30.34 | 46.98M | $1.43B | $52.64M | $11.48M | $1.38B |
| 2025-09-30 | $29.70 | 37.93M | $1.13B | $251.36M | $11.87M | $887.07M |
| 2025-06-30 | $11.37 | 35.44M | $403.01M | $55.07M | $11.86M | $359.8M |
| 2025-03-31 | $10.03 | 19.29M | $193.46M | $57.6M | $7.84M | $143.7M |
| 2024-12-31 | $17.74 | 19.29M | $342.17M | $56.8M | $1.48M | $286.84M |
| 2024-09-30 | $20.48 | 19.17M | $392.62M | $39.31M | $1.65M | $354.95M |
| 2024-06-30 | $25.44 | 20.12M | $511.78M | $110.16M | $1.82M | $403.43M |
| 2024-03-31 | $20.80 | 19.46M | $404.71M | $74.27M | $1.98M | $332.42M |
| 2023-12-31 | $20.80 | 18.08M | $376.04M | $70.17M | $2.15M | $308.02M |
| 2023-09-30 | $20.80 | 19.1M | $397.24M | -$ | -$ | $397.24M |
| 2023-06-30 | $20.80 | 20.12M | $418.43M | -$ | -$ | $418.43M |